TriApex US Laboratories Listed by nightspire Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
TriApex US Laboratories was listed by the nightspire ransomware group on January 20, 2026, after internal files were exfiltrated in an attack. Anyone connected to the organization should check their records and take steps to protect their information.
Breaking down the breach
The incident was reported through the appearance of TriApex US Laboratories on the nightspire group's leak site. The group claims responsibility for exfiltrating internal files in a ransomware operation. No confirmation of the claim from TriApex US Laboratories has been noted in available reporting. The number of people affected remains unknown, and no timeline for the intrusion itself has been disclosed.
Who is nightspire?
Nightspire is a ransomware group that maintains a public leak site to list organizations it claims to have targeted. Such groups commonly employ double-extortion tactics, combining file encryption with the threat of data publication. Public records show nightspire has appeared in connection with other listings in recent years, though independent verification of each claim varies.
Who is TriApex US Laboratories?
TriApex US Laboratories operates in the laboratory sector, which routinely processes samples and maintains records tied to testing, research, or clinical work. Organizations in this field hold operational and technical documentation that can include sensitive operational details. A listing involving such an entity draws attention because laboratory records often intersect with regulated data environments.
The information in question
The only data type referenced in the listing is internal files exfiltrated during the ransomware attack. No inventory of specific file categories or record counts has been released. The exact scope of any personal or operational information therefore stays unconfirmed at this time.
- Internal files exfiltrated in ransomware attack
- Listing reported on January 20, 2026
- Number of individuals affected remains unknown
What's at stake
Exposure of internal laboratory files can create operational and compliance questions for the organization. For any individuals whose information appears in those files, potential downstream effects include targeted follow-on contact or misuse of whatever identifiers are present. Without a confirmed data inventory, the scale of those effects cannot be quantified from public sources.
What to do if you're exposed
Monitor accounts tied to any laboratory services you have used and review statements from TriApex US Laboratories when they become available. Enable multi-factor authentication on relevant portals and request copies of your records where permitted. Readers can run a free exposure scan of their email to check whether their information has surfaced in known breach data.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
Red-Line Listed by nightspire Ransomware GroupBK Tomorrow Listed by nightspire Ransomware GroupE-Fci Listed by nightspire Ransomware GroupCPG Documentation Listed by nightspire Ransomware GroupLatest breaches
Publicly posted by nightspire — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.